
Breakthrough sickle cell gene therapy: what made it work A report on the development of a gene therapy for sickle cell disease describes how multiple scientific advances converged to create a treatment that can correct the underlying defect in a way earlier a…

Stuart Orkin and Swee Lay Thein shared a Breakthrough Prize in Life Sciences for their research on genetic causes of sickle cell disease and beta-thalassemia that set the stage for approved gene therapies. The treatments are not accessible to everyone, though
The AAV vector manufacturing market is mainly fueled by the expanding landscape of gene therapy research and development, as AAV vectors are extensively utilized for therapeutic gene delivery because of their strong safety profile and ability to provide susta…